Going Where No Skincare Has Gone Before

For the past 20 years, traditional skincare delivery could only take ingredients so far. Which is why we have relied on needles and other minimally-invasive procedures to get larger molecules, like hyaluronic acid, into the skin….until now
image description

Leveraging 20 Years Of Biotech & Skincare Expertise


Ourself developed a scientifically advanced delivery technology that redefines what’s possible in topical skincare.

image description

Introducing the Tiered-Release Vesicles™ To Ensure Deep Ingredient Delivery

Patented ingredient capsules contain 18+ tiers packed with precision-targeted ingredients and sends them further, faster – straight to the layers of the skin where they have the most visible impact.

Going where no skincare has gone before

treatment areas

Hyperpigmentation

Lips

Fine Lines & Wrinkles

Hyperpigmentation

Our patent-pending Brightening Intides™–Intelligent Peptides–help target and eliminate dark spots before they even begin. Niacinamide and vitamin c also work to improve your skin’s tone for a brighter, more even-toned complexion.

Shop Now
Daily Dark Spot Intercept
Tiered-Release Vesicle™ Technology
$260
shop
image description
Lips

Our Subtopical Plumping Technology™ works to infuse hyaluronic acid to reclaim volume, suppleness, and definition, and to enhance the color of your lips. Enjoy fuller, natural-looking lips without injections.

Shop Now
The Lip Plumping and Enhancing Regimen
Fuller Lips + Glossy Finish
$190
shop
image description
Fine Lines & Wrinkles

Stay tuned, coming soon.

treatment areas

Founded by disruptors


We knew that if we wanted to create a new category of skincare we had to create new technology. Our team of biochemists, engineers, and doctors worked together to create a Tiered-Release Vesicle™ Technology that's never been seen in skincare before.

  • image description

    Lauren Otsuki, M.Sc

    Co-Founder and Chief Innovation Officer

    Lauren Otsuki is the Co-Founder and Chief Innovation Officer of Ourself and its parent company, GLO Pharma. Lauren has founded and managed five successful biotech firms, DexCom, NovaCardia, Oncternal Therapeutics, Alastin Skincare, and Prometheus Biosciences, where she was responsible for development and operations. She has played an integral role in implementing scientific research and development into skincare product formulation with leading professional skincare companies like SkinMedica and Alastin Skincare, and now in aesthetics with Ourself and GLO Pharma.

  • image description

    Scott Glenn

    Co-Founder

    Scott Glenn is the Co-Founder of Ourself and its parent company GLO Pharma.  A serial entrepreneur, who seeks solutions to the medical industry’s toughest challenges, Scott has developed and advanced numerous therapeutics, devices, and diagnostics aimed at addressing a range of medical conditions including cancer, diabetes, and autoimmune diseases. Over the last 20 years, he has founded and managed over 25 successful biotech companies including Quidel and Prometheus Labs and pioneered two professional skincare brands, Alastin Skincare and SkinMedica.